[HTML][HTML] Arginine metabolism: a potential target in pancreatic cancer therapy
JS Yang, CC Wang, JD Qiu, B Ren… - Chinese medical …, 2021 - journals.lww.com
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
Arginine metabolism: a potential target in pancreatic cancer therapy.
JS Yang, CC Wang, JD Qiu, B Ren… - Chinese Medical …, 2020 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
Arginine metabolism: a potential target in pancreatic cancer therapy
JS Yang, CC Wang, JD Qiu, B Ren, L You - Chinese Medical Journal, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Abstract</jats: title>< jats: p> Pancreatic ductal adenocarcinoma
(PDAC) is an extremely malignant disease, which has an extremely low survival rate of< 9 …
(PDAC) is an extremely malignant disease, which has an extremely low survival rate of< 9 …
Arginine metabolism: a potential target in pancreatic cancer therapy
Y Jin-Shou, W Cheng-Cheng… - Chinese Medical …, 2021 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
Arginine metabolism: a potential target in pancreatic cancer therapy
JS Yang, CC Wang, JD Qiu, B Ren, L You - Chinese Medical Journal, 2021 - mednexus.org
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
[HTML][HTML] Arginine metabolism: a potential target in pancreatic cancer therapy
JS Yang, CC Wang, JD Qiu, B Ren… - Chinese Medical …, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
Arginine metabolism: a potential target in pancreatic cancer therapy
JS YANG, CC WANG, JD QIU, B REN… - Chinese Medical …, 2020 - pesquisa.bvsalud.org
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
Arginine metabolism: a potential target in pancreatic cancer therapy
JS Yang, CC Wang, JD Qiu, B Ren… - Chinese medical …, 2020 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …